Efficacy and safety data from patients with advanced non-squamous NSCLC and brain metastases from the nivolumab expanded access programme (EAP) in Italy

Lucio Crinò, Angelo Delmonte, F. Roila et al.|Annals of Oncology|2017

Cited by 7